Nexgel (NXGLW) Gains from Investment Securities (2019 - 2025)
Nexgel's (NXGLW) quarterly Gains from Investment Securities came in at -$6000.0 in Q4 2025, down 110.91% YoY from $55000.0 in Q4 2024, and up 25.0% on a QoQ basis from -$8000.0 in Q3 2025.
Nexgel (NXGLW) Gains from Investment Securities (2019 - 2025) Analysis & Trends
Nexgel (NXGLW) has 7 years of Gains from Investment Securities data on file, last reported at -$6000.0 in Q4 2025.
- Quarterly Gains from Investment Securities fell 110.91% year-over-year to -$6000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$118000.0 (down 755.56% YoY) and the FY2025 annual result came in at -$118000.0, down 755.56% from the prior year.
- Gains from Investment Securities improved to -$6000.0 in Q4 2025, from -$8000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $130000.0 in Q1 2022 to a low of -$130000.0 in Q4 2022.
- A 5-year average of -$12850.0 and a median of -$9500.0 in 2023 frame the typical range for Gains from Investment Securities.
- The widest YoY moves for Gains from Investment Securities: up 2266.67% in 2022, down 6600.0% in 2022.
- Tracing NXGLW's Gains from Investment Securities over 5 years: stood at $2000.0 in 2021, then sank by 6600.0% to -$130000.0 in 2022, then soared by 161.54% to $80000.0 in 2023, then plunged by 31.25% to $55000.0 in 2024, then plunged by 110.91% to -$6000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$6000.0 (Q4 2025), -$8000.0 (Q3 2025), and -$13000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -13,000.00 |
| Mar 31, 2025 | -91,000.00 |
| Mar 31, 2025 | -91,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -79,000.00 |
| Jun 30, 2024 | -79,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Sep 30, 2023 | -19,000.00 |
| Sep 30, 2023 | -19,000.00 |